$MBAIF
Rejuvenation Medical Group is using $MBAI's MedMatrix AI Platform to enhance its clinic operations, displaying MBAI's partnering capability & MedMatrix's scalability. This advanced AI tech offers data reporting, forecasting & more, aiding clinic revenue growth while improving patient experience.
https://www.reddit.com/r/ArtificialInteligence/duplicates/1bkksog/medbright_ai_investments_inc_mbaic_enhances/
$MBAIF If you're interested in investing in early stage broadly applicable AI technology, I'd recommend checking out MedBright AI (MBAI.c MBAIF) - In addressing a US$726 billion market with the commercialization of its MedMatrix AI product suite, MBAI is targeting a revolution in the global outpatient clinical services with its AI platform: https://www.reddit.com/r/ArtificialInteligence/comments/1bdaocb/medmatrix_ai_market_expander_adopted_by_southern/
$MBAIF Further proving the easy multiples and scalability its broadly applicableMedMatrix AI technology has, MedBright AI (MBAI.c MBAIF) announced that a Southern California clinic has adopted MedMatrix AI Market Expander to launch the opening of its new clinic location: https://www.reddit.com/r/ArtificialInteligence/comments/1bdaocb/medmatrix_ai_market_expander_adopted_by_southern/
In addressing a US$726 billion market with the commercialization of its MedMatrix AI product suite, MBAI is targeting a revolution in the global outpatient clinical services with its AI platform.
$MBAIF $MBAI has unveiled revenue-linked pricing for its MedMatrix AI Platform for outpatient clinics. The post below highlights MedMatrix's advanced AI infrastructure, timely launch amidst the outpatient clinical services market's growth to $729B & how it is positioned to disrupt healthcare tech landscape.
https://www.reddit.com/r/Baystreetbets/comments/1b98utg/revolutionizing_outpatient_clinical_services/?utm_source=share&utm_medium=web2x&context=3
$MBAIF For anyone looking to invest in early stage broadly applicable AI technology, I'd recommend checking out MedBright AI (MBAI.c MBAIF) as they're addressing a US$726 billion market with the commercialization of its MedMatrix AI product suite - MBAI could see easy multiples here based on the already established and substantial scalability: https://www.reddit.com/r/ArtificialInteligence/comments/1b7i48m/gotomarket_pricing_for_ai_produce_suite/
$MBAIF MBAI.c unveils pricing for MedMatrix, a multifunction AI platform for healthcare clinics, offering flexible pricing tied to client success and increased revenue, reflecting a commitment to value delivery. MBAI is looking to reshape outpatient services globally, targeting a $726 billion market.
Details + analysis here⬇️
https://www.reddit.com/r/Pennystocksv2/comments/1b7l07z/unleashing_the_potential_of_ai_in_healthcare/
$MBAIF MBAI.c unveils pricing for MedMatrix, a multifunction AI platform for healthcare clinics, offering flexible pricing tied to client success and increased revenue, reflecting a commitment to value delivery. MBAI is looking to reshape outpatient services globally, targeting a $726 billion market.
Details + analysis here⬇️
https://www.reddit.com/r/Wallstreetbetsnew/comments/1b4c7pt/west_red_lake_gold_mines_ltd_sees_strong_volume/?utm_source=share&utm_medium=web2x&context=3
$MBAIF MedBright AI has revealed a little more of their pricing strategy. They are going to be taking 1-3% of total clinic revenue, where the market is over $700B. Cashed up & expanding sales to capture more of the market. #AI #MedTech https://ceo.ca/@globenewswire/medmatrix-go-to-market-pricing-announced-for-ai-product
$MBAIF Based on the large addressable market and the evidence of quick scaling of deployments we've seen so far, Medbright AI (MBAI.c MBAIF) could see easy multiples now that it's moving to full commercialization of MedMatrix, an AI data-analytics platform that drastically improve healthcare operations and enhance clinic revenue by 10% at no additional cost to the clinic: https://www.reddit.com/r/CanadianStockExchange/comments/1b45g8o/medbright_ai_mbaic_mbaif_movies_ai_platform/
$MBAIF Beta testing for $MBAI.c's MedMatrix AI Health-tech Platform has concluded & its full commercialization is imminent. MGMT is preparing to launch a revenue-generating strategy & has chosen a 5-feature product suite for MedMatrix to sell into the global health clinic/hospital market. MBAI up 6% today.
Breakdown here: https://www.reddit.com/r/Wealthsimple_Penny/comments/1b3eny8/medbrights_mbaic_medmatrix_ai_platform_unveiling/?utm_source=share&utm_medium=web2x&context=3
Yesterday, $MBAIF revealed that its MedMatrix AI Platform has concluded beta testing w/ inaugural clients, closing up on high volume as a result.
https://www.globenewswire.com/news-release/2024/02/27/2835946/0/en/MedMatrix-Product-Moves-from-Beta-to-Full-Commercialization-Announces-AI-Product-Suite.html
W/ this MedMatrix is moving from beta to full-commercialization & a go-to-market strategy is in the works. $MBAIF's beta customers, including a Yale School of Medicine Affiliated Clinic Group, are expected to be transitioned to MedMatrix's full version. Breakdown here⬇️
https://www.reddit.com/r/smallstreetbets/comments/1b1s0ck/revolutionizing_outpatient_healthcare_with_ai/
$MBAIF With the completion of its beta testing for MedMatrix as announced yestereday, MedBright AI is set to move the AI data analytics platform to full commercialization with an AI product suite - could see easy multiples here given its substantial scalability and vast addressable market: https://www.reddit.com/r/Canadapennystocks/comments/1b1gsht/today_medbright_ai_mbaic_mbaif_announces/
$MBAIF Targeting a $200 billion dollar healthcare problem, I've been impressed with this AI platform providers expansion as of late - just last week they announced that its Disease Insights Platform is now being used in hospitals to improve the detection of kidney stone disease recurrence: https://www.reddit.com/r/GlobalMarketNews/comments/1axfuy6/medbright_ai_mbaic_mbaif_announces_limmi_disease/
$MBAIF Announcing yesterday that its Limmi Disease Insights Platform is now being used in hospitals to improve the detection of kidney stone disease recurrence, I've been quite impressed with MedBright AI's (MBAI.c MBAIF) continued expansion as of late: https://www.reddit.com/r/GlobalMarketNews/comments/1axfuy6/medbright_ai_mbaic_mbaif_announces_limmi_disease/
